Ohki Healthcare Holdings Co.,Ltd.

TSE:3417 Voorraadrapport

Marktkapitalisatie: JP¥12.3b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Ohki Healthcare HoldingsLtd Beheer

Beheer criteriumcontroles 2/4

De CEO Ohki Healthcare HoldingsLtd's is Hidemasa Matsui, benoemd in Jun2018, heeft een ambtstermijn van 6.33 jaar. bezit rechtstreeks 0.4% van de aandelen van het bedrijf, ter waarde ¥ 49.56M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.7 jaar en 13.8 jaar.

Belangrijke informatie

Hidemasa Matsui

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO6.3yrs
Eigendom CEO0.4%
Management gemiddelde ambtstermijn7.7yrs
Gemiddelde ambtstermijn bestuur13.8yrs

Recente managementupdates

Recent updates

These 4 Measures Indicate That Ohki Healthcare HoldingsLtd (TSE:3417) Is Using Debt Reasonably Well

Aug 06
These 4 Measures Indicate That Ohki Healthcare HoldingsLtd (TSE:3417) Is Using Debt Reasonably Well

We Like Ohki Healthcare HoldingsLtd's (TSE:3417) Earnings For More Than Just Statutory Profit

May 24
We Like Ohki Healthcare HoldingsLtd's (TSE:3417) Earnings For More Than Just Statutory Profit

Ohki Healthcare HoldingsLtd (TYO:3417) Has A Somewhat Strained Balance Sheet

Apr 22
Ohki Healthcare HoldingsLtd (TYO:3417) Has A Somewhat Strained Balance Sheet

Ohki Healthcare Holdings Co.,Ltd.'s (TYO:3417) Stock Been Rising: Are Strong Financials Guiding The Market?

Jan 31
Ohki Healthcare Holdings Co.,Ltd.'s (TYO:3417) Stock Been Rising: Are Strong Financials Guiding The Market?

Does Ohki Healthcare HoldingsLtd (TYO:3417) Have A Healthy Balance Sheet?

Jan 13
Does Ohki Healthcare HoldingsLtd (TYO:3417) Have A Healthy Balance Sheet?

Ohki Healthcare HoldingsLtd (TYO:3417) Has Gifted Shareholders With A Fantastic 210% Total Return On Their Investment

Dec 26
Ohki Healthcare HoldingsLtd (TYO:3417) Has Gifted Shareholders With A Fantastic 210% Total Return On Their Investment

Ohki Healthcare HoldingsLtd (TYO:3417) Is Growing Earnings But Are They A Good Guide?

Dec 08
Ohki Healthcare HoldingsLtd (TYO:3417) Is Growing Earnings But Are They A Good Guide?

Is Ohki Healthcare Holdings Co.,Ltd. (TYO:3417) A Smart Pick For Income Investors?

Nov 20
Is Ohki Healthcare Holdings Co.,Ltd. (TYO:3417) A Smart Pick For Income Investors?

CEO

Hidemasa Matsui (50 yo)

6.3yrs

Tenure

Mr. Hidemasa Matsui serves as President and Representative Director of Ohki Healthcare Holdings Co.,Ltd. since June 2018 and has served as its Director since June 2006. He served as General Manager of Gene...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Hideo Matsui
Executive Chairman45.8yrsgeen gegevens1.58%
¥ 194.4m
Hidemasa Matsui
President & Representative Director6.3yrsgeen gegevens0.40%
¥ 49.5m
Yoshinobu Ube
Senior MD & Representative Director18.3yrsgeen gegevens0.13%
¥ 16.2m
Masaaki Ueki
Senior MD & Director9yrsgeen gegevens0.066%
¥ 8.1m

7.7yrs

Gemiddelde duur

63.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 3417 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.7 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Hideo Matsui
Executive Chairman45.8yrsgeen gegevens1.58%
¥ 194.4m
Hidemasa Matsui
President & Representative Director18.3yrsgeen gegevens0.40%
¥ 49.5m
Yoshinobu Ube
Senior MD & Representative Director24.3yrsgeen gegevens0.13%
¥ 16.2m
Masaaki Ueki
Senior MD & Director20.3yrsgeen gegevens0.066%
¥ 8.1m
Shingo Kawakami
Independent Outside Director15.3yrsgeen gegevensgeen gegevens
Shuji Arayama
Director12.3yrsgeen gegevensgeen gegevens
An Tanaka
Outside Audit & Supervisory Board Member8.2yrsgeen gegevensgeen gegevens
Masahiro Miyamoto
Auditor1.8yrsgeen gegevens0.0073%
¥ 899.9k
Ichiro Komazaki
Outside Audit & Supervisory Board Member4.3yrsgeen gegevensgeen gegevens
Kenichi Yamaoka
Directorless than a yeargeen gegevens0.0073%
¥ 899.9k

13.8yrs

Gemiddelde duur

68yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 3417 zijn ervaren en ervaren (gemiddelde ambtstermijn van 13.8 jaar).